Harmony Biosciences Holdings, Inc. (HRMY)

Last Closing Price: 33.11 (2026-11-18)

Cash Flow from Operating Activities (Quarterly)

Cash Flow from Operating Activities: A company's cash flows from operations.

Harmony Biosciences Holdings, Inc. (HRMY) had Cash Flow from Operating Activities of $196.88M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$268.92M
$48.20M
$80.69M
$188.23M
$214.72M
$54.20M
$5.05M
$59.25M
$59.25M
$48.20M
$48.20M
$48.20M
$48.20M
$54.20M
$59.59M
58.41M
59.68M
$0.83
$0.81
Balance Sheet Financials
$934.83M
--
$543.41M
$1.48B
$271.54M
$129.10M
$134.47M
$406.01M
$1.07B
$1.00B
$1.07B
58.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities
$196.88M
$-307.47M
$5.18M
$752.77M
$647.37M
$-105.40M
$28.00M
--
--
Fundamental Metrics & Ratios
3.44
--
--
0.11
0.14
70.00%
20.15%
20.15%
--
22.03%
17.92%
$196.88M
--
--
--
0.18
13.74
2.11
42.75
4.49%
4.82%
3.26%
4.01%
$18.26
$3.30
$3.30